As the proud owner of five cats, I
can’t imagine a world in which I couldn’t pet and play with my
four-legged friends every single day. But for some people with bad
allergies, missing out on purrs and
snuggles is just a part of life. Thankfully, the struggle may
be in the rearview mirror for allergic cat-lovers thanks to a new
vaccine. According to a July 2019 study in
The Journal of Allergy and Clinical
Immunology, researchers at University Hospital in
Zurich, Switzerland, are developing a brand-new vaccine called
HyopCat, which treats Fel d 1 – or the “major cat allergen” – that
affects 10 percent of the Western world.
Although more research on the vaccine needs to be completed,
this news gives hope to individuals who are forced to love felines
from afar. So how exactly does it work? In short, a cat gets
injected with a vaccine that lowers the amount of Fel d 1 present
in their fur, making humans less allergic. So
far, the vaccine has been “tolerated well” and hasn’t had an “overt
toxic effect” in test subjects.
Scientists involved in the study say that the vaccine could
benefit both people and cats alike. “Both human subjects and
animals could profit from this treatment because allergic cat
owners would reduce their risk of developing chronic diseases, such
as asthma, and become more tolerant of their cats, which therefore
could stay in the households and not need to be relinquished to
animal shelters,” explained researchers.
Fingers crossed that the new vaccine, if successful, will get
even more needy kitties out of shelters and
placed in happy homes!
Source: FS – All – Food and Nutrition Blogs
This New Vaccine May Prevent People From Being Allergic to Cats, and Talk About Good News!